MyFinsight
Home
Blog
About
Contact
Download
Download image
Property and equipment,
gross
$82,149K
Accounts receivable, net
and contract assets
$457,989K
Cash and cash
equivalents
$309,749K
Inventories
$155,467K
Prepaid expenses and
other current assets
$70,958K
Marketable securities,
available-for-sale
$8,873K
Subtotal
$46,934K
Right of use of assets
$35,296K
Accumulated depreciation
and amortization
$35,215K
Total current assets
$1,003,036K
Intangible assets, net
$951,955K
Goodwill
$582,323K
Property and equipment,
net
$82,230K
Prepaid expenses and
other assets
$50,915K
Restricted cash
$2,260K
Total assets
$2,672,719K
Total liabilities and
stockholders equity
$2,672,719K
Total liabilities
$2,453,083K
Total stockholders
equity
$219,636K
Accumulated other
comprehensive loss
-$12,703K
Long-term debt, net
$1,935,896K
Total current
liabilities
$363,210K
Other long-term
liabilities
$106,448K
Deferred tax
liabilities, net
$47,529K
Retained earnings
$204,835K
Additional paid-in capital
$27,386K
Common stock - 0.001 par
value 300,000 shares...
$118K
Current portion of
long-term debt, net
$208,743K
Accrued expenses
$140,369K
Accounts payable
$14,098K
Back
Back
Balance Sheet
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)
source: myfinsight.com